Short Interest in P3 Health Partners Inc. (NASDAQ:PIII) Rises By 293.3%

P3 Health Partners Inc. (NASDAQ:PIII) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totaling 283,541 shares, a growth of 293.3% from the April 30th total of 72,094 shares. Approximately 4.8% of the company’s shares are sold short. Based on an average daily volume of 6,174,785 shares, the days-to-cover ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

PIII has been the subject of several recent analyst reports. UBS Group set a $14.00 target price on P3 Health Partners in a research note on Friday, May 15th. Lake Street Capital reissued a “buy” rating and set a $14.00 target price (up from $4.00) on shares of P3 Health Partners in a research note on Friday, May 15th. Weiss Ratings raised P3 Health Partners from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday. Finally, TD Cowen reaffirmed a “hold” rating and issued a $14.00 target price (up from $3.00) on shares of P3 Health Partners in a research report on Friday, May 22nd. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $14.00.

P3 Health Partners Trading Down 26.0%

P3 Health Partners stock traded down $4.29 during trading on Friday, hitting $12.18. The company had a trading volume of 202,836 shares, compared to its average volume of 3,893,211. P3 Health Partners has a 1-year low of $1.52 and a 1-year high of $16.89. The company’s 50 day simple moving average is $5.02 and its 200-day simple moving average is $4.14. The stock has a market cap of $88.18 million, a price-to-earnings ratio of -0.32 and a beta of 0.48.

P3 Health Partners (NASDAQ:PIII) last posted its earnings results on Thursday, May 14th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of ($4.85) by $5.17. P3 Health Partners had a negative net margin of 8.57% and a negative return on equity of 302.33%. The firm had revenue of $386.39 million during the quarter, compared to the consensus estimate of $391.45 million.

Hedge Funds Weigh In On P3 Health Partners

An institutional investor recently bought a new position in P3 Health Partners stock. Lido Advisors LLC bought a new position in shares of P3 Health Partners Inc. (NASDAQ:PIII) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 10,748 shares of the company’s stock, valued at approximately $33,000. Lido Advisors LLC owned approximately 0.15% of P3 Health Partners at the end of the most recent quarter. Institutional investors own 7.75% of the company’s stock.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.